Withholding Perioperative Steroids in Patients Undergoing Transsphenoidal Resection for Pituitary Disease: Randomized Prospective Clinical Trial to Assess Safety

Keyphrases

• Withholding 100%
• Pituitary Diseases 100%
• Randomized Prospective Clinical Trial 100%
• Transsphenoidal Resection 100%
• Transsphenoidal Surgery 100%
• Perioperative Steroids 100%
• HPA Axis 75%
• Cortisol Level 75%
• After Surgery 50%
• Adrenal Insufficiency 50%
• Hyperglycemia 25%
• Hydrocortisone 25%
• Length of Hospital Stay 25%
• Complication Risk 25%
• Postoperative Complications 25%
• Pituitary Tumor 25%
• Diabetes Insipidus 25%
• Intravenous Dexamethasone 25%
• Pituitary Pathology 25%

Medicine and Dentistry

• Clinical Trial 100%
• Hydrocortisone 100%
• Glucocorticoid 100%
• Hypophysis Disease 100%
• Transsphenoidal Surgery 100%
• Surgery 100%
• Hypothalamic-Pituitary-Adrenal Axis 75%
• Adrenal Insufficiency 50%
• Hyperglycemia 25%
• Postoperative Complication 25%
• Pituitary Tumour 25%
• Dexamethasone 25%
• Diabetes Insipidus 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Glucocorticoid 100%
• Clinical Trial 100%
• Hydrocortisone 100%
• Hypophysis Disease 100%
• Adrenal Insufficiency 50%
• Hyperglycemia 25%
• Dexamethasone 25%
• Postoperative Complication 25%
• Hypophysis Tumor 25%
• Diabetes Insipidus 25%